Autonomous aldosterone overproduction represents the underlying condition of 5–10% of
patients with arterial hypertension and carries a significant burden of mortality and morbidity …

Primary aldosteronism is a frequent cause of secondary hypertension requiring a specific
pharmacological treatment with mineralocorticoid receptor antagonist or with unilateral …

The last decade has witnessed the healthcare system going paperless with increased use of
electronic healthcare records. Artificial intelligence tools including smartphones and smart …

Context Many antihypertensive medications modulate the renin-angiotensin-aldosterone
system, possibly skewing the diagnosis and subtyping of primary aldosteronism (PA) …

Abstract Introduction:[11 C] Metomidate ([11 C] MTO), the methyl ester analogue of
etomidate, was developed as a positron emission tomography (PET) radiotracer for …

Background The current first-line screening test for primary hyperaldosteronism is the
plasma aldosterone: renin ratio; however, renin assays have several disadvantages and the …

Hypertension is a leading cardiovascular risk factor that remains difficult to manage in a
large segment of the population. Secondary causes of hypertension, which are amenable to …

Connshing syndrome (CoSh)(adrenal-related synchronous aldosterone (A) and cortisol (C)
excess) represents a distinct entity among PA (primary hyperaldosteronisms) named by W …

Background Primary aldosteronism (PA) accounts for 3.2–12.7% of hypertension in primary
care but is often diagnosed late, if at all. A delayed or missed diagnosis leads to poor blood …

Background: Primary aldosteronism is the most common causes of secondary hypertension.
Patients suffering from this clinical syndrome have an increased cardiovascular risk and …